Publications by authors named "A Edmundson"
Current approaches to the surgical management of Crohn's disease in Australia and New Zealand.
Int J Colorectal Dis
January 2025
Purpose: Given the evolving literature regarding the optimal surgical approach to mitigate post-operative recurrence of Crohn's disease (CD), this survey study aimed to elucidate the practices and preferences of colorectal surgeons in Australia and New Zealand (ANZ) in their surgical management of CD.
Methods: Colorectal surgical consultants and fellows (n = 337) registered with the Colorectal Surgical Society of Australia and New Zealand (CSSANZ) were invited by email in April 2022 to participate in a cross-sectional survey consisting of basic demographics and 12 questions relating to their usual surgical practice and preferred operative strategy.
Results: A total of 135 responses were received (39.
Background: The management of Crohn's disease (CD) complicated by ileosigmoid fistula (ISF) remains a challenge, and Australian outcomes have not previously been reported.
Methods: A retrospective review of a tertiary colorectal inflammatory bowel disease unit, across public and private sites, from 2005 to 2023 to identify adult patients having undergone operative management of ISF.
Results: Twenty-nine patients underwent surgery for ISF in the study period.
Restaurants are important settings for foodborne illness transmission. Environmental health agencies routinely inspect restaurants to assess compliance with food safety regulations. They also evaluate foodborne illness complaints from consumers to detect potential outbreaks of foodborne illness.
View Article and Find Full Text PDFArticle Synopsis
- * A case-control study involving 3,647 healthcare personnel showed that bivalent vaccine effectiveness (VE) was about 34.1%, with the highest effectiveness (54.8%) observed shortly after administration, declining as time passed.
- * The study highlights that while bivalent doses initially provide substantial protection against COVID-19, their effectiveness significantly wanes after two months, suggesting the need for ongoing monitoring and potential updates to vaccination strategies.